Cell And Gene Therapies

Transitioning cell and gene therapy manufacturing from manual lab processes to scalable, industrial production requires overcoming severe cleanroom capacity constraints while adhering to strict regulatory requirements. End-to-end automated platforms streamline complex workflows—such as cell seeding, media replacement, expansion, and harvesting—within enclosed, sterile environments. Integrating modular barrier technology, cell-friendly peristaltic pumps, and multi-docking connectors helps protect sensitive cultures from mechanical stress and contamination risks. Furthermore, real-time monitoring of critical parameters like temperature, pH, and dissolved oxygen, combined with automated digital batch reporting, guarantees seamless traceability and consistent batch-to-batch product quality. This systematic approach drastically lowers per-product manufacturing costs, minimizes physical footprint requirements, and shortens production timelines.

Download the brochure to learn how automated platforms elevate cell therapy manufacturing efficiency.